Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04016610 · ClinicalTrials.gov registry record · NA
Proof of Concept (POC) Study of the Soliton's Acoustic Scar Reduction (ASR) Treatment for the Treatment of Keloid Scar
A NA study, sponsored by Soliton.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04016610 is a NA study that has completed, run by Soliton. The registered enrollment target is 9 participants.
The verdict
NCT04016610, a NA study, has completed, sponsored by Soliton.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
To evaluate the safety, and efficacy of the ASR device for the temporary improvement in the appearance of a keloids.
Interventions
- DEVICE Soliton's Acoustic Scar Reduction (SAR)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-07-09 |
| Est. Completion | 2020-02-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04016610
The ClinicalTrials.gov registry entry for NCT04016610 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Soliton, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Soliton's Acoustic Scar Reduction (SAR) is the first listed.
NCT04016610 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04016610 about?
NCT04016610 is a clinical study titled "Proof of Concept (POC) Study of the Soliton's Acoustic Scar Reduction (ASR) Treatment for the Treatment of Keloid Scar". To evaluate the safety, and efficacy of the ASR device for the temporary improvement in the appearance of a keloids.
What is the current status of trial NCT04016610?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2019-07-09. Estimated completion is 2020-02-12.
What interventions are being tested in trial NCT04016610?
The interventions under investigation include: Soliton's Acoustic Scar Reduction (SAR) (DEVICE).
Who is sponsoring clinical trial NCT04016610?
This trial is sponsored by Soliton, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.